Siemens Healthineers AG Key Executives
This section highlights Siemens Healthineers AG's key executives, including their titles and compensation details.
Find Contacts at Siemens Healthineers AG
(Showing 0 of )
Siemens Healthineers AG Earnings
This section highlights Siemens Healthineers AG's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Date:
May 07, 2025
Time:
Before Market
Est. EPS:
$0.57
Status:
Unconfirmed
Last Earnings Results
Date:
February 06, 2025
EPS:
$0.53
Est. EPS:
$0.48
Revenue:
$5.48B
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q1 | 2025 | 2025-02-08 | N/A | N/A |
| Read Transcript | Q4 | 2024 | 2024-11-06 | $0.64 | $0.67 |
| Read Transcript | Q3 | 2024 | 2024-07-31 | $0.52 | $0.52 |
| Read Transcript | Q1 | 2024 | 2024-05-07 | $0.52 | $0.55 |
| Read Transcript | Q4 | 2023 | 2023-11-09 | N/A | N/A |
| Read Transcript | Q3 | 2023 | 2023-08-02 | $0.51 | $0.53 |
| Read Transcript | Q2 | 2023 | 2023-05-11 | N/A | N/A |
| Read Transcript | Q1 | 2023 | 2023-02-03 | N/A | N/A |
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Healthcare
Medical - Devices
$51.70
Stock Price
$57.87B
Market Cap
-
Employees
Erlangen, None
Location
Financial Statements
Access annual & quarterly financial statements for Siemens Healthineers AG, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | September 30, 2024 | September 30, 2023 | September 30, 2022 | September 30, 2021 | September 30, 2020 |
|---|---|---|---|---|---|
| Revenue | $22.36B | $21.68B | $21.71B | $18.00B | $14.46B |
| Cost of Revenue | $13.89B | $13.97B | $13.58B | $11.04B | $8.88B |
| Gross Profit | $8.47B | $7.71B | $8.14B | $6.95B | $5.58B |
| Gross Profit Ratio | 37.87% | 35.60% | 37.47% | 38.60% | 38.59% |
| Research and Development Expenses | $1.92B | $1.87B | $1.78B | $1.55B | $1.34B |
| General and Administrative Expenses | $3.68B | $3.61B | $3.41B | $2.82B | $2.28B |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $3.68B | $3.61B | $3.41B | $2.82B | $2.28B |
| Other Expenses | $- | $103.00M | $20.00M | $32.00M | $15.00M |
| Operating Expenses | $5.60B | $5.58B | $5.21B | $4.39B | $3.64B |
| Cost and Expenses | $19.49B | $19.55B | $18.79B | $15.44B | $12.52B |
| Interest Income | $119.00M | $85.00M | $48.00M | $33.00M | $53.00M |
| Interest Expense | $476.00M | $296.00M | $118.00M | $83.00M | $76.00M |
| Depreciation and Amortization | $1.22B | $1.56B | $1.34B | $1.04B | $815.00M |
| EBITDA | $4.22B | $3.78B | $4.26B | $3.52B | $2.84B |
| EBITDA Ratio | 18.88% | 17.44% | 19.62% | 19.53% | 19.44% |
| Operating Income | $2.87B | $2.22B | $2.92B | $2.48B | $2.00B |
| Operating Income Ratio | 12.83% | 10.26% | 13.44% | 13.76% | 13.80% |
| Total Other Income Expenses Net | $-344.00M | $-205.00M | $-124.00M | $-59.00M | $-41.00M |
| Income Before Tax | $2.52B | $1.93B | $2.80B | $2.40B | $1.95B |
| Income Before Tax Ratio | 11.29% | 8.89% | 12.89% | 13.36% | 13.51% |
| Income Tax Expense | $564.00M | $403.00M | $746.00M | $658.00M | $532.00M |
| Net Income | $1.94B | $1.51B | $2.04B | $1.73B | $1.41B |
| Net Income Ratio | 8.68% | 6.96% | 9.39% | 9.60% | 9.76% |
| EPS | $1.74 | $1.35 | $1.82 | $1.57 | $1.41 |
| EPS Diluted | $1.74 | $1.34 | $1.81 | $1.56 | $1.41 |
| Weighted Average Shares Outstanding | 1.12B | 1.12B | 1.12B | 1.10B | 1.00B |
| Weighted Average Shares Outstanding Diluted | 1.12B | 1.12B | 1.13B | 1.10B | 1.00B |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.48B | $6.33B | $5.42B | $5.43B | $5.18B | $6.06B | $5.20B | $5.35B | $5.08B | $6.00B | $5.19B | $5.46B | $5.07B | $5.16B | $5.00B | $3.96B | $3.87B | $3.88B | $3.31B | $3.69B |
| Cost of Revenue | $3.33B | $3.92B | $3.33B | $3.43B | $3.21B | $3.76B | $3.27B | $3.72B | $3.22B | $3.68B | $3.32B | $3.42B | $3.16B | $3.21B | $3.08B | $2.46B | $2.30B | $2.44B | $2.04B | $2.18B |
| Gross Profit | $2.15B | $2.41B | $2.09B | $2.01B | $1.97B | $2.29B | $1.94B | $1.62B | $1.86B | $2.32B | $1.87B | $2.04B | $1.91B | $1.96B | $1.92B | $1.51B | $1.57B | $1.44B | $1.27B | $1.50B |
| Gross Profit Ratio | 39.26% | 38.00% | 38.50% | 36.90% | 38.00% | 37.90% | 37.20% | 30.40% | 36.60% | 38.70% | 36.00% | 37.30% | 37.60% | 37.90% | 38.40% | 38.00% | 40.50% | 37.10% | 38.47% | 40.73% |
| Research and Development Expenses | $481.00M | $496.00M | $484.00M | $474.00M | $464.00M | $486.00M | $474.00M | $465.00M | $441.00M | $497.00M | $436.00M | $444.00M | $408.00M | $483.00M | $403.00M | $331.00M | $329.00M | $340.00M | $328.00M | $339.00M |
| General and Administrative Expenses | $973.00M | $962.00M | $918.00M | $899.00M | $902.00M | $942.00M | $881.00M | $902.00M | $882.00M | $939.00M | $840.00M | $826.00M | $803.00M | $855.00M | $843.00M | $569.00M | $549.00M | $565.00M | $529.00M | $565.00M |
| Selling and Marketing Expenses | $- | $- | $- | $-13.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $973.00M | $962.00M | $918.00M | $886.00M | $902.00M | $942.00M | $881.00M | $902.00M | $882.00M | $939.00M | $840.00M | $826.00M | $803.00M | $855.00M | $843.00M | $569.00M | $549.00M | $565.00M | $529.00M | $565.00M |
| Other Expenses | $698.00M | $- | $9.00M | $- | $- | $- | $- | $68.00M | $16.00M | $8.00M | $-3.00M | $8.00M | $6.00M | $13.00M | $3.00M | $11.00M | $5.00M | $8.00M | $6.00M | $- |
| Operating Expenses | $2.15B | $1.46B | $1.40B | $1.36B | $1.37B | $1.43B | $1.37B | $1.44B | $1.34B | $1.44B | $1.27B | $1.28B | $1.22B | $1.35B | $1.25B | $911.00M | $883.00M | $913.00M | $863.00M | $904.00M |
| Cost and Expenses | $5.48B | $5.38B | $4.74B | $4.79B | $4.58B | $5.20B | $4.63B | $5.16B | $4.56B | $5.12B | $4.59B | $4.70B | $4.38B | $4.56B | $4.33B | $3.37B | $3.19B | $3.35B | $2.90B | $3.09B |
| Interest Income | $31.00M | $29.00M | $27.00M | $32.00M | $32.00M | $25.00M | $20.00M | $21.00M | $19.00M | $14.00M | $14.00M | $11.00M | $9.00M | $13.00M | $10.00M | $5.00M | $6.00M | $8.00M | $8.00M | $9.00M |
| Interest Expense | $108.00M | $142.00M | $116.00M | $111.00M | $107.00M | $102.00M | $83.00M | $66.00M | $45.00M | $37.00M | $32.00M | $24.00M | $25.00M | $25.00M | $23.00M | $19.00M | $16.00M | $15.00M | $21.00M | $20.00M |
| Depreciation and Amortization | $305.00M | $309.00M | $295.00M | $328.00M | $291.00M | $327.00M | $314.00M | $582.00M | $334.00M | $331.00M | $343.00M | $355.00M | $314.00M | $284.00M | $347.00M | $202.00M | $206.00M | $216.00M | $208.00M | $186.00M |
| EBITDA | $1.03B | $1.29B | $1.01B | $916.00M | $941.00M | $1.20B | $913.00M | $791.00M | $852.00M | $1.23B | $939.00M | $1.13B | $1.00B | $903.00M | $956.00M | $838.00M | $889.00M | $781.00M | $632.00M | $788.00M |
| EBITDA Ratio | 18.79% | 20.46% | 18.13% | 17.92% | 18.18% | 19.88% | 17.55% | 14.78% | 17.21% | 20.47% | 17.37% | 20.75% | 19.73% | 17.53% | 19.12% | 21.13% | 21.41% | 20.15% | 19.08% | 21.38% |
| Operating Income | $- | $950.00M | $688.00M | $646.00M | $650.00M | $877.00M | $599.00M | $208.00M | $540.00M | $896.00M | $558.00M | $778.00M | $681.00M | $608.00M | $672.00M | $595.00M | $683.00M | $525.00M | $411.00M | $597.00M |
| Operating Income Ratio | 0.00% | 15.01% | 12.69% | 11.89% | 12.56% | 14.48% | 11.52% | 3.89% | 10.64% | 14.93% | 10.76% | 14.25% | 13.44% | 11.77% | 13.44% | 15.01% | 17.66% | 13.54% | 12.41% | 16.20% |
| Total Other Income Expenses Net | $617.00M | $-106.00M | $-93.00M | $-104.00M | $-107.00M | $-84.00M | $-65.00M | $-46.00M | $-45.00M | $-19.00M | $-32.00M | $-7.00M | $-28.00M | $-12.00M | $-86.00M | $-33.00M | $-77.00M | $25.00M | $-8.00M | $-15.00M |
| Income Before Tax | $617.00M | $844.00M | $595.00M | $542.00M | $543.00M | $775.00M | $516.00M | $142.00M | $495.00M | $859.00M | $526.00M | $754.00M | $661.00M | $596.00M | $586.00M | $617.00M | $606.00M | $550.00M | $403.00M | $582.00M |
| Income Before Tax Ratio | 11.26% | 13.34% | 10.97% | 9.97% | 10.49% | 12.80% | 9.92% | 2.66% | 9.75% | 14.32% | 10.14% | 13.81% | 13.04% | 11.54% | 11.72% | 15.56% | 15.67% | 14.19% | 12.17% | 15.79% |
| Income Tax Expense | $138.00M | $221.00M | $123.00M | $110.00M | $110.00M | $235.00M | $65.00M | $33.00M | $70.00M | $224.00M | $162.00M | $171.00M | $190.00M | $130.00M | $191.00M | $169.00M | $169.00M | $118.00M | $131.00M | $168.00M |
| Net Income | $474.00M | $616.00M | $469.00M | $426.00M | $431.00M | $537.00M | $445.00M | $105.00M | $421.00M | $631.00M | $363.00M | $579.00M | $466.00M | $462.00M | $390.00M | $443.00M | $432.00M | $429.00M | $270.00M | $411.00M |
| Net Income Ratio | 8.65% | 9.73% | 8.65% | 7.84% | 8.33% | 8.87% | 8.56% | 1.96% | 8.29% | 10.52% | 7.00% | 10.60% | 9.19% | 8.95% | 7.80% | 11.17% | 11.17% | 11.07% | 8.15% | 11.15% |
| EPS | $0.42 | $0.55 | $0.42 | $0.38 | $0.39 | $0.48 | $0.40 | $0.09 | $0.38 | $0.57 | $0.32 | $0.52 | $0.41 | $0.41 | $0.35 | $0.41 | $0.40 | $0.43 | $0.27 | $0.41 |
| EPS Diluted | $0.42 | $0.55 | $0.42 | $0.38 | $0.38 | $0.48 | $0.40 | $0.09 | $0.38 | $0.56 | $0.32 | $0.51 | $0.41 | $0.41 | $0.35 | $0.41 | $0.40 | $0.43 | $0.27 | $0.41 |
| Weighted Average Shares Outstanding | 1.13B | 1.12B | 1.12B | 1.12B | 1.12B | 1.12B | 1.12B | 1.12B | 1.12B | 1.11B | 1.12B | 1.11B | 1.12B | 1.11B | 1.11B | 1.08B | 1.08B | 1.00B | 1.00B | 1.00B |
| Weighted Average Shares Outstanding Diluted | 1.13B | 1.12B | 1.12B | 1.12B | 1.13B | 1.12B | 1.12B | 1.12B | 1.12B | 1.13B | 1.13B | 1.14B | 1.14B | 1.11B | 1.11B | 1.08B | 1.08B | 1.00B | 1.00B | 1.00B |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | September 30, 2024 | September 30, 2023 | September 30, 2022 | September 30, 2021 | September 30, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $2.68B | $1.64B | $1.44B | $1.32B | $656.00M |
| Short Term Investments | $92.00M | $124.00M | $162.00M | $79.00M | $31.00M |
| Cash and Short Term Investments | $2.77B | $1.77B | $1.60B | $1.40B | $687.00M |
| Net Receivables | $6.39B | $7.48B | $7.06B | $6.01B | $7.08B |
| Inventory | $4.14B | $4.26B | $3.97B | $3.15B | $2.27B |
| Other Current Assets | $1.13B | $1.44B | $1.42B | $257.00M | $228.00M |
| Total Current Assets | $14.44B | $14.14B | $13.38B | $10.82B | $10.27B |
| Property Plant Equipment Net | $4.47B | $4.21B | $4.27B | $3.71B | $2.77B |
| Goodwill | $17.66B | $18.12B | $19.06B | $17.51B | $9.04B |
| Intangible Assets | $7.06B | $7.73B | $8.71B | $8.21B | $1.91B |
| Goodwill and Intangible Assets | $24.72B | $25.84B | $27.77B | $25.72B | $10.95B |
| Long Term Investments | $1.41B | $154.00M | $131.00M | $178.00M | $104.00M |
| Tax Assets | $476.00M | $416.00M | $575.00M | $481.00M | $419.00M |
| Other Non-Current Assets | $532.00M | $1.92B | $2.92B | $1.24B | $580.00M |
| Total Non-Current Assets | $31.61B | $32.55B | $35.68B | $31.34B | $14.83B |
| Other Assets | $- | $- | $- | $- | $-1.00M |
| Total Assets | $46.05B | $46.68B | $49.06B | $42.16B | $25.09B |
| Account Payables | $2.13B | $2.20B | $2.31B | $1.92B | $1.36B |
| Short Term Debt | $2.78B | $197.00M | $233.00M | $225.00M | $167.00M |
| Tax Payables | $391.00M | $849.00M | $960.00M | $756.00M | $574.00M |
| Deferred Revenue | $3.63B | $10.87B | $3.75B | $7.68B | $5.63B |
| Other Current Liabilities | $2.65B | $6.56B | $4.77B | $7.16B | $3.41B |
| Total Current Liabilities | $11.57B | $13.44B | $12.02B | $10.06B | $7.29B |
| Long Term Debt | $13.97B | $436.00M | $461.00M | $457.00M | $314.00M |
| Deferred Revenue Non-Current | $- | $12.71B | $- | $12.86B | $4.29B |
| Deferred Tax Liabilities Non-Current | $1.51B | $1.66B | $2.11B | $2.08B | $470.00M |
| Other Non-Current Liabilities | $756.00M | $301.00M | $14.61B | $361.00M | $224.00M |
| Total Non-Current Liabilities | $16.23B | $15.11B | $17.18B | $15.76B | $5.29B |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $27.81B | $28.55B | $29.20B | $25.82B | $12.58B |
| Preferred Stock | $- | $- | $- | $369.00M | $741.00M |
| Common Stock | $1.13B | $1.13B | $1.13B | $1.13B | $1.07B |
| Retained Earnings | $2.15B | $1.38B | $894.00M | $-300.00M | $-1.28B |
| Accumulated Other Comprehensive Income Loss | $- | $340.00M | $2.36B | $-369.00M | $-741.00M |
| Other Total Stockholders Equity | $14.92B | $-607.00M | $-405.00M | $15.12B | $13.44B |
| Total Stockholders Equity | $18.20B | $18.08B | $19.84B | $16.32B | $12.50B |
| Total Equity | $18.25B | $18.13B | $19.85B | $16.34B | $12.51B |
| Total Liabilities and Stockholders Equity | $46.05B | $46.68B | $49.06B | $42.16B | $25.09B |
| Minority Interest | $49.00M | $52.00M | $16.00M | $18.00M | $13.00M |
| Total Liabilities and Total Equity | $46.05B | $46.68B | $49.06B | $42.16B | $25.09B |
| Total Investments | $1.41B | $278.00M | $293.00M | $257.00M | $135.00M |
| Total Debt | $16.23B | $633.00M | $732.00M | $753.00M | $481.00M |
| Net Debt | $13.55B | $-1.01B | $-704.00M | $-569.00M | $-175.00M |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $2.77B | $2.68B | $2.06B | $2.31B | $1.47B | $1.64B | $1.78B | $1.37B | $1.35B | $1.44B | $1.37B | $1.08B | $1.31B | $1.32B | $1.24B | $559.00M | $563.00M | $656.00M | $622.00M | $845.00M |
| Short Term Investments | $229.00M | $229.00M | $238.00M | $335.00M | $511.00M | $124.00M | $605.00M | $381.00M | $564.00M | $162.00M | $441.00M | $274.00M | $197.00M | $79.00M | $234.00M | $101.00M | $125.00M | $31.00M | $122.00M | $131.00M |
| Cash and Short Term Investments | $3.00B | $2.77B | $2.06B | $2.31B | $1.98B | $1.77B | $2.38B | $1.75B | $1.92B | $1.60B | $1.81B | $1.35B | $1.50B | $1.40B | $1.47B | $660.00M | $688.00M | $687.00M | $744.00M | $976.00M |
| Net Receivables | $- | $6.67B | $6.49B | $6.26B | $6.67B | $7.48B | $6.30B | $6.41B | $6.80B | $7.06B | $5.68B | $6.12B | $6.03B | $6.05B | $6.08B | $18.24B | $7.52B | $7.08B | $3.81B | $3.93B |
| Inventory | $4.61B | $4.14B | $4.72B | $4.64B | $4.54B | $4.26B | $4.39B | $4.22B | $4.22B | $3.97B | $3.92B | $3.67B | $3.41B | $3.15B | $3.21B | $2.42B | $2.38B | $2.27B | $2.58B | $2.39B |
| Other Current Assets | $7.22B | $858.00M | $916.00M | $1.05B | $1.17B | $716.00M | $1.24B | $1.03B | $1.17B | $870.00M | $1.03B | $887.00M | $692.00M | $293.00M | $670.00M | $358.00M | $451.00M | $258.00M | $508.00M | $476.00M |
| Total Current Assets | $14.83B | $14.44B | $14.19B | $14.25B | $13.84B | $14.14B | $13.70B | $13.03B | $13.54B | $13.38B | $12.01B | $11.76B | $11.43B | $10.82B | $11.19B | $21.68B | $10.91B | $10.27B | $7.53B | $7.64B |
| Property Plant Equipment Net | $4.77B | $4.47B | $4.38B | $4.22B | $4.19B | $4.21B | $4.09B | $4.09B | $4.13B | $4.27B | $4.04B | $3.91B | $3.79B | $3.71B | $3.46B | $2.88B | $2.77B | $2.77B | $2.76B | $2.71B |
| Goodwill | $18.46B | $17.66B | $18.02B | $17.91B | $17.74B | $18.12B | $17.79B | $17.86B | $18.08B | $19.06B | $18.45B | $17.88B | $17.61B | $17.51B | $16.82B | $9.06B | $8.79B | $9.04B | $9.29B | $9.46B |
| Intangible Assets | $7.40B | $7.06B | $7.37B | $7.43B | $7.43B | $7.73B | $7.52B | $7.57B | $8.05B | $8.71B | $8.40B | $8.12B | $8.13B | $8.21B | $8.39B | $1.88B | $1.83B | $1.91B | $1.98B | $2.03B |
| Goodwill and Intangible Assets | $25.86B | $24.72B | $25.38B | $25.34B | $25.17B | $25.84B | $25.31B | $25.43B | $26.13B | $27.77B | $26.84B | $25.99B | $25.73B | $25.72B | $25.22B | $10.94B | $10.62B | $10.95B | $11.27B | $11.49B |
| Long Term Investments | $1.54B | $1.41B | $1.59B | $1.49B | $860.00M | $154.00M | $893.00M | $1.43B | $1.29B | $131.00M | $1.60B | $1.03B | $1.06B | $178.00M | $443.00M | $365.00M | $172.00M | $104.00M | $384.00M | $423.00M |
| Tax Assets | $531.00M | $476.00M | $546.00M | $551.00M | $490.00M | $416.00M | $480.00M | $500.00M | $513.00M | $575.00M | $613.00M | $528.00M | $411.00M | $481.00M | $538.00M | $459.00M | $464.00M | $419.00M | $351.00M | $301.00M |
| Other Non-Current Assets | $782.00M | $532.00M | $532.00M | $499.00M | $981.00M | $1.92B | $1.05B | $829.00M | $1.00B | $2.92B | $903.00M | $761.00M | $692.00M | $1.24B | $695.00M | $439.00M | $426.00M | $580.00M | $408.00M | $427.00M |
| Total Non-Current Assets | $33.49B | $31.61B | $32.44B | $32.10B | $31.69B | $32.55B | $31.82B | $32.29B | $33.07B | $35.68B | $34.00B | $32.22B | $31.68B | $31.34B | $30.36B | $15.09B | $14.46B | $14.83B | $15.17B | $15.36B |
| Other Assets | $- | $- | $- | $- | $-1.00M | $- | $- | $-1.00M | $- | $- | $-1.00M | $- | $- | $- | $1.00M | $- | $- | $-1.00M | $- | $1.00M |
| Total Assets | $48.32B | $46.05B | $46.63B | $46.34B | $45.53B | $46.68B | $45.52B | $45.31B | $46.61B | $49.06B | $46.01B | $43.98B | $43.12B | $42.16B | $41.55B | $36.78B | $25.37B | $25.09B | $22.70B | $23.00B |
| Account Payables | $2.22B | $2.13B | $1.99B | $2.02B | $2.06B | $2.20B | $2.06B | $2.11B | $2.10B | $2.31B | $2.10B | $2.25B | $1.99B | $1.92B | $2.02B | $1.48B | $1.35B | $1.36B | $1.30B | $1.38B |
| Short Term Debt | $- | $2.78B | $2.44B | $2.32B | $- | $197.00M | $- | $201.00M | $- | $233.00M | $- | $- | $- | $225.00M | $- | $- | $- | $167.00M | $- | $252.00M |
| Tax Payables | $406.00M | $391.00M | $470.00M | $371.00M | $472.00M | $849.00M | $381.00M | $560.00M | $720.00M | $960.00M | $471.00M | $390.00M | $482.00M | $756.00M | $480.00M | $283.00M | $376.00M | $574.00M | $308.00M | $261.00M |
| Deferred Revenue | $- | $3.63B | $3.75B | $3.73B | $8.34B | $10.87B | $10.15B | $3.71B | $3.61B | $3.75B | $3.59B | $3.38B | $6.22B | $7.68B | $5.85B | $5.34B | $5.25B | $5.63B | $3.13B | $3.34B |
| Other Current Liabilities | $8.92B | $2.65B | $6.26B | $2.40B | $6.28B | $10.19B | $7.99B | $10.88B | $5.48B | $8.52B | $5.74B | $5.95B | $4.61B | $7.16B | $4.70B | $4.61B | $4.47B | $5.19B | $2.30B | $3.23B |
| Total Current Liabilities | $11.55B | $11.57B | $11.17B | $10.84B | $12.40B | $13.44B | $14.11B | $13.75B | $11.91B | $12.02B | $11.89B | $11.98B | $10.12B | $10.06B | $9.88B | $8.36B | $8.05B | $7.29B | $5.75B | $6.01B |
| Long Term Debt | $- | $13.46B | $14.42B | $14.04B | $- | $436.00M | $- | $415.00M | $- | $461.00M | $- | $- | $- | $457.00M | $- | $- | $- | $314.00M | $- | $-839.00M |
| Deferred Revenue Non-Current | $- | $- | $497.00M | $444.00M | $12.70B | $12.71B | $11.65B | $- | $- | $- | $- | $- | $13.00B | $12.86B | $13.26B | $12.57B | $4.07B | $4.29B | $6.16B | $6.16B |
| Deferred Tax Liabilities Non-Current | $1.59B | $1.51B | $1.53B | $1.57B | $1.62B | $1.66B | $1.67B | $1.73B | $1.90B | $2.11B | $2.27B | $2.20B | $2.10B | $2.08B | $2.35B | $467.00M | $451.00M | $470.00M | $434.00M | $574.00M |
| Other Non-Current Liabilities | $15.35B | $1.27B | $725.00M | $776.00M | $929.00M | $301.00M | $879.00M | $12.07B | $14.21B | $14.61B | $13.43B | $12.88B | $916.00M | $362.00M | $727.00M | $611.00M | $592.00M | $224.00M | $632.00M | $315.00M |
| Total Non-Current Liabilities | $16.94B | $16.23B | $17.18B | $16.83B | $15.25B | $15.11B | $14.20B | $14.22B | $16.10B | $17.18B | $15.69B | $15.07B | $16.02B | $15.76B | $16.34B | $13.65B | $5.11B | $5.29B | $7.22B | $7.36B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $28.49B | $27.81B | $28.34B | $27.67B | $27.65B | $28.55B | $28.32B | $27.96B | $28.01B | $29.20B | $27.59B | $27.05B | $26.14B | $25.82B | $26.22B | $22.01B | $13.16B | $12.58B | $12.97B | $13.38B |
| Preferred Stock | $- | $- | $- | $- | $299.00M | $- | $- | $- | $- | $- | $- | $- | $- | $85.00M | $709.00M | $- | $- | $- | $- | $- |
| Common Stock | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.13B | $1.07B | $1.07B | $1.00B | $1.00B |
| Retained Earnings | $2.63B | $2.15B | $1.61B | $2.21B | $1.72B | $1.38B | $801.00M | $405.00M | $1.34B | $894.00M | $322.00M | $-117.00M | $198.00M | $-300.00M | $-751.00M | $-1.18B | $-876.00M | $-1.28B | $-1.71B | $-1.99B |
| Accumulated Other Comprehensive Income Loss | $- | $- | $102.00M | $-45.00M | $-299.00M | $340.00M | $18.00M | $293.00M | $636.00M | $2.36B | $1.32B | $297.00M | $73.00M | $-85.00M | $-709.00M | $16.75B | $12.14B | $12.73B | $10.43B | $10.66B |
| Other Total Stockholders Equity | $16.02B | $14.92B | $15.39B | $15.35B | $15.28B | $15.23B | $15.24B | $15.51B | $15.48B | $15.46B | $15.64B | $15.61B | $15.56B | $15.58B | $15.64B | $14.81B | $11.99B | $13.44B | $10.84B | $10.61B |
| Total Stockholders Equity | $19.78B | $18.20B | $18.24B | $18.63B | $17.83B | $18.08B | $17.19B | $17.34B | $18.59B | $19.84B | $18.41B | $16.92B | $16.96B | $16.32B | $15.31B | $14.76B | $12.19B | $12.50B | $9.72B | $9.62B |
| Total Equity | $19.83B | $18.25B | $18.28B | $18.68B | $17.88B | $18.13B | $17.20B | $17.35B | $18.60B | $19.85B | $18.42B | $16.92B | $16.98B | $16.34B | $15.33B | $14.77B | $12.21B | $12.51B | $9.73B | $9.62B |
| Total Liabilities and Stockholders Equity | $48.32B | $46.05B | $46.63B | $46.34B | $45.53B | $46.68B | $45.52B | $45.31B | $46.61B | $49.06B | $46.01B | $43.98B | $43.12B | $42.16B | $41.55B | $36.78B | $25.37B | $25.09B | $22.70B | $23.00B |
| Minority Interest | $53.00M | $49.00M | $46.00M | $42.00M | $48.00M | $52.00M | $15.00M | $10.00M | $14.00M | $16.00M | $10.00M | $8.00M | $19.00M | $18.00M | $20.00M | $8.00M | $14.00M | $13.00M | $8.00M | $5.00M |
| Total Liabilities and Total Equity | $48.32B | $46.05B | $46.63B | $46.34B | $45.53B | $46.68B | $45.52B | $45.31B | $46.61B | $49.06B | $46.01B | $43.98B | $43.12B | $42.16B | $41.55B | $36.78B | $25.37B | $25.09B | $22.70B | $23.00B |
| Total Investments | $1.77B | $1.41B | $1.59B | $1.49B | $1.37B | $278.00M | $1.50B | $1.81B | $1.85B | $293.00M | $2.04B | $1.30B | $1.25B | $257.00M | $677.00M | $466.00M | $297.00M | $135.00M | $506.00M | $554.00M |
| Total Debt | $- | $16.23B | $16.86B | $16.36B | $670.00M | $633.00M | $623.00M | $620.00M | $660.00M | $732.00M | $683.00M | $680.00M | $674.00M | $753.00M | $619.00M | $488.00M | $481.00M | $481.00M | $541.00M | $570.00M |
| Net Debt | $-2.77B | $13.55B | $14.80B | $14.05B | $-796.00M | $-1.01B | $-1.16B | $-750.00M | $-692.00M | $-704.00M | $-690.00M | $-396.00M | $-634.00M | $-569.00M | $-618.00M | $-71.00M | $-82.00M | $-175.00M | $-81.00M | $-275.00M |
Annual Cash Flow
| Breakdown | September 30, 2024 | September 30, 2023 | September 30, 2022 | September 30, 2021 | September 30, 2020 |
|---|---|---|---|---|---|
| Net Income | $1.94B | $1.52B | $2.05B | $1.75B | $1.42B |
| Depreciation and Amortization | $1.22B | $1.56B | $1.34B | $1.04B | $815.00M |
| Deferred Income Tax | $- | $-265.00M | $-266.00M | $-87.00M | $39.00M |
| Stock Based Compensation | $- | $124.00M | $106.00M | $92.00M | $88.00M |
| Change in Working Capital | $-605.00M | $-602.00M | $-831.00M | $354.00M | $-188.00M |
| Accounts Receivables | $-422.00M | $-773.00M | $-489.00M | $-718.00M | $53.00M |
| Inventory | $39.00M | $-453.00M | $-481.00M | $-22.00M | $-332.00M |
| Accounts Payables | $-62.00M | $-20.00M | $247.00M | $318.00M | $1.00M |
| Other Working Capital | $-160.00M | $644.00M | $-108.00M | $776.00M | $90.00M |
| Other Non Cash Items | $-91.00M | $-361.00M | $-62.00M | $-206.00M | $-122.00M |
| Net Cash Provided by Operating Activities | $2.47B | $2.12B | $2.50B | $2.93B | $1.93B |
| Investments in Property Plant and Equipment | $-696.00M | $-838.00M | $-852.00M | $-674.00M | $-557.00M |
| Acquisitions Net | $34.00M | $-235.00M | $-31.00M | $-13.47B | $-1.35B |
| Purchases of Investments | $-4.00M | $-7.00M | $-2.00M | $-12.00M | $-6.00M |
| Sales Maturities of Investments | $- | $12.00M | $17.00M | $12.00M | $5.00M |
| Other Investing Activities | $- | $-1.00M | $13.00M | $1.00M | $-1.00M |
| Net Cash Used for Investing Activities | $-666.00M | $-1.07B | $-868.00M | $-14.14B | $-1.91B |
| Debt Repayment | $-211.00M | $-232.00M | $-149.00M | $-138.00M | $-101.00M |
| Common Stock Issued | $- | $- | $1.00M | $2.31B | $2.71B |
| Common Stock Repurchased | $-11.00M | $-421.00M | $-309.00M | $-255.00M | $-67.00M |
| Dividends Paid | $-1.06B | $-1.07B | $-955.00M | $-856.00M | $-798.00M |
| Other Financing Activities | $-15.00M | $1.03B | $-231.00M | $10.78B | $-1.99B |
| Net Cash Used Provided by Financing Activities | $-1.30B | $-380.00M | $-1.64B | $11.84B | $-249.00M |
| Effect of Forex Changes on Cash | $-66.00M | $-155.00M | $122.00M | $34.00M | $-31.00M |
| Net Change in Cash | $436.00M | $206.00M | $114.00M | $666.00M | $-264.00M |
| Cash at End of Period | $2.68B | $1.64B | $1.44B | $1.32B | $656.00M |
| Cash at Beginning of Period | $2.25B | $1.44B | $1.32B | $656.00M | $920.00M |
| Operating Cash Flow | $2.47B | $2.12B | $2.50B | $2.93B | $1.93B |
| Capital Expenditure | $-696.00M | $-838.00M | $-852.00M | $-674.00M | $-557.00M |
| Free Cash Flow | $1.77B | $1.28B | $1.65B | $2.26B | $1.37B |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $478.00M | $617.00M | $468.00M | $426.00M | $432.00M | $540.00M | $451.00M | $108.00M | $426.00M | $635.00M | $364.00M | $583.00M | $472.00M | $466.00M | $395.00M | $448.00M | $437.00M | $433.00M | $271.00M | $415.00M |
| Depreciation and Amortization | $305.00M | $309.00M | $295.00M | $328.00M | $291.00M | $327.00M | $314.00M | $582.00M | $334.00M | $332.00M | $343.00M | $355.00M | $314.00M | $284.00M | $347.00M | $202.00M | $206.00M | $216.00M | $208.00M | $186.00M |
| Deferred Income Tax | $- | $- | $- | $- | $- | $-265.00M | $- | $- | $- | $-266.00M | $- | $- | $- | $-87.00M | $- | $- | $- | $- | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- | $124.00M | $- | $- | $- | $106.00M | $- | $- | $- | $92.00M | $- | $- | $- | $88.00M | $- | $- |
| Change in Working Capital | $-75.00M | $226.00M | $-37.00M | $-495.00M | $-251.00M | $-238.00M | $-154.00M | $180.00M | $-393.00M | $-259.00M | $19.00M | $-476.00M | $-114.00M | $3.00M | $221.00M | $-20.00M | $149.00M | $285.00M | $20.00M | $-399.00M |
| Accounts Receivables | $364.00M | $-498.00M | $-32.00M | $-162.00M | $270.00M | $-601.00M | $-126.00M | $-11.00M | $-35.00M | $-620.00M | $314.00M | $-450.00M | $267.00M | $-427.00M | $-138.00M | $-175.00M | $11.00M | $-197.00M | $172.00M | $-137.00M |
| Inventory | $-257.00M | $472.00M | $-59.00M | $-62.00M | $-312.00M | $186.00M | $-187.00M | $-54.00M | $-399.00M | $42.00M | $-149.00M | $-211.00M | $-162.00M | $158.00M | $-106.00M | $36.00M | $-110.00M | $225.00M | $-214.00M | $-142.00M |
| Accounts Payables | $- | $136.00M | $-47.00M | $-45.00M | $-106.00M | $111.00M | $-40.00M | $30.00M | $-121.00M | $175.00M | $-205.00M | $241.00M | $36.00M | $-128.00M | $330.00M | $102.00M | $- | $- | $- | $- |
| Other Working Capital | $-182.00M | $116.00M | $101.00M | $-226.00M | $-103.00M | $66.00M | $199.00M | $215.00M | $162.00M | $144.00M | $59.00M | $-265.00M | $48.00M | $-155.00M | $327.00M | $-56.00M | $259.00M | $60.00M | $234.00M | $-257.00M |
| Other Non Cash Items | $272.00M | $87.00M | $690.00M | $905.00M | $-102.00M | $169.00M | $-134.00M | $-149.00M | $-244.00M | $30.00M | $-62.00M | $-80.00M | $47.00M | $-149.00M | $50.00M | $-128.00M | $22.00M | $-49.00M | $-28.00M | $11.00M |
| Net Cash Provided by Operating Activities | $980.00M | $1.24B | $688.00M | $239.00M | $370.00M | $798.00M | $477.00M | $721.00M | $123.00M | $738.00M | $664.00M | $382.00M | $719.00M | $604.00M | $1.01B | $502.00M | $814.00M | $885.00M | $471.00M | $213.00M |
| Investments in Property Plant and Equipment | $-170.00M | $-213.00M | $-185.00M | $-166.00M | $-132.00M | $-241.00M | $-192.00M | $-205.00M | $-200.00M | $-284.00M | $-186.00M | $-219.00M | $-163.00M | $-223.00M | $-161.00M | $-143.00M | $-146.00M | $-176.00M | $-135.00M | $-130.00M |
| Acquisitions Net | $-204.00M | $- | $63.00M | $-35.00M | $-6.00M | $-230.00M | $192.00M | $-2.00M | $-3.00M | $-4.00M | $-14.00M | $-4.00M | $-9.00M | $-21.00M | $-13.41B | $-4.00M | $-31.00M | $176.00M | $-5.00M | $-13.00M |
| Purchases of Investments | $- | $-2.00M | $- | $- | $-3.00M | $-2.00M | $-5.00M | $- | $- | $-1.00M | $-1.00M | $- | $- | $-1.00M | $-5.00M | $-2.00M | $-4.00M | $-1.00M | $135.00M | $-1.00M |
| Sales Maturities of Investments | $2.00M | $- | $68.00M | $- | $10.00M | $3.00M | $1.00M | $8.00M | $- | $4.00M | $1.00M | $1.00M | $11.00M | $8.00M | $1.00M | $1.00M | $1.00M | $1.00M | $2.00M | $1.00M |
| Other Investing Activities | $- | $3.00M | $-1.00M | $- | $7.00M | $1.00M | $-193.00M | $-1.00M | $1.00M | $3.00M | $- | $1.00M | $-1.00M | $2.00M | $-4.00M | $-1.00M | $1.00M | $- | $-136.00M | $- |
| Net Cash Used for Investing Activities | $-372.00M | $-212.00M | $-122.00M | $-201.00M | $-131.00M | $-470.00M | $-197.00M | $-200.00M | $-202.00M | $-285.00M | $-200.00M | $-221.00M | $-162.00M | $-235.00M | $-13.58B | $-149.00M | $-179.00M | $-176.00M | $-139.00M | $-143.00M |
| Debt Repayment | $-490.00M | $-357.00M | $239.00M | $727.00M | $- | $-332.00M | $304.00M | $731.00M | $144.00M | $-43.00M | $-45.00M | $-30.00M | $-51.00M | $-60.00M | $-34.00M | $-48.00M | $-30.00M | $-58.00M | $-30.00M | $705.00M |
| Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $1.00M | $- | $- | $- | $- | $- | $2.32B | $- | $- | $- | $- |
| Common Stock Repurchased | $- | $-2.00M | $- | $-9.00M | $- | $-76.00M | $-302.00M | $-16.00M | $-27.00M | $-222.00M | $-2.00M | $-17.00M | $-67.00M | $-90.00M | $-7.00M | $-33.00M | $-130.00M | $- | $- | $-27.00M |
| Dividends Paid | $- | $- | $-1.06B | $- | $- | $- | $- | $-1.07B | $- | $- | $- | $-955.00M | $- | $- | $- | $-856.00M | $- | $- | $- | $-798.00M |
| Other Financing Activities | $-50.00M | $-201.00M | $-43.00M | $-558.00M | $-391.00M | $30.00M | $258.00M | $-122.00M | $-40.00M | $-152.00M | $-159.00M | $583.00M | $-485.00M | $-160.00M | $13.26B | $-1.73B | $-563.00M | $-3.31B | $-520.00M | $-43.00M |
| Net Cash Used Provided by Financing Activities | $-540.00M | $-558.00M | $-824.00M | $207.00M | $-391.00M | $-378.00M | $260.00M | $-374.00M | $112.00M | $-416.00M | $-206.00M | $-419.00M | $-603.00M | $-310.00M | $13.22B | $-350.00M | $-723.00M | $-662.00M | $-550.00M | $-163.00M |
| Effect of Forex Changes on Cash | $23.00M | $-41.00M | $10.00M | $-12.00M | $-23.00M | $22.00M | $-65.00M | $-31.00M | $-81.00M | $26.00M | $38.00M | $26.00M | $32.00M | $27.00M | $19.00M | $-7.00M | $-6.00M | $-12.00M | $-7.00M | $4.00M |
| Net Change in Cash | $91.00M | $627.00M | $-249.00M | $839.00M | $-176.00M | $-137.00M | $409.00M | $18.00M | $-84.00M | $63.00M | $297.00M | $-232.00M | $-14.00M | $85.00M | $678.00M | $-4.00M | $-93.00M | $34.00M | $-223.00M | $-89.00M |
| Cash at End of Period | $2.77B | $2.68B | $2.06B | $2.31B | $1.47B | $1.64B | $1.78B | $1.37B | $1.35B | $1.44B | $1.37B | $1.08B | $1.31B | $1.32B | $1.24B | $559.00M | $563.00M | $656.00M | $622.00M | $845.00M |
| Cash at Beginning of Period | $2.68B | $2.06B | $2.31B | $1.47B | $1.64B | $1.78B | $1.37B | $1.35B | $1.44B | $1.37B | $1.08B | $1.31B | $1.32B | $1.24B | $559.00M | $563.00M | $656.00M | $622.00M | $845.00M | $934.00M |
| Operating Cash Flow | $980.00M | $1.24B | $688.00M | $239.00M | $370.00M | $798.00M | $477.00M | $721.00M | $123.00M | $738.00M | $664.00M | $382.00M | $719.00M | $604.00M | $1.01B | $502.00M | $814.00M | $885.00M | $471.00M | $213.00M |
| Capital Expenditure | $-170.00M | $-213.00M | $-185.00M | $-166.00M | $-132.00M | $-241.00M | $-192.00M | $-205.00M | $-200.00M | $-284.00M | $-186.00M | $-219.00M | $-163.00M | $-223.00M | $-161.00M | $-143.00M | $-146.00M | $-176.00M | $-135.00M | $-130.00M |
| Free Cash Flow | $810.00M | $1.03B | $503.00M | $73.00M | $238.00M | $557.00M | $285.00M | $516.00M | $-77.00M | $454.00M | $478.00M | $163.00M | $556.00M | $381.00M | $852.00M | $359.00M | $668.00M | $709.00M | $336.00M | $83.00M |
Siemens Healthineers AG Dividends
Explore Siemens Healthineers AG's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
1.77%
Dividend Payout Ratio
54.74%
Dividend Paid & Capex Coverage Ratio
1.40x
Siemens Healthineers AG Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.95 | $0.95 | February 19, 2025 | February 20, 2025 | February 21, 2025 | |
| $0.95 | $0.95 | April 19, 2024 | April 22, 2024 | April 23, 2024 | |
| $0.95 | $0.95 | February 16, 2023 | February 17, 2023 | February 20, 2023 | |
| $0.85 | $0.85 | February 16, 2022 | February 17, 2022 | February 18, 2022 | |
| $0.8 | $0.8 | February 15, 2021 | February 16, 2021 | February 17, 2021 | |
| $0.8 | $0.8 | February 13, 2020 | February 14, 2020 | February 17, 2020 | November 06, 2019 |
| $0.7 | $0.7 | February 06, 2019 | February 07, 2019 | February 08, 2019 | January 15, 2019 |
Siemens Healthineers AG News
Read the latest news about Siemens Healthineers AG, including recent articles, headlines, and updates.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for SHL.DE.